Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit.
Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit.
复制标题
DOI:
10.3389/fnins.2022.1048945
复制
发表时间:
2022
影响因子:
4.3
通讯作者:
Huddleston, Daniel E.
中科院分区:
文献类型:
--
作者:
Langley, Jason;Hwang, Kristy S.;Hu, Xiaoping P.;Huddleston, Daniel E.
关键词:
Striatal dopamine transporter (DAT) imaging using 123I-ioflupane single photon positron emitted computed tomography (SPECT) (DaTScan, GE) identifies 5−20% of newly diagnosed Parkinson’s disease (PD) subjects enrolling in clinical studies to have scans without evidence of dopaminergic deficit (SWEDD). These individuals meet diagnostic criteria for PD, but do not clinically progress as expected, and they are not believed to have neurodegenerative Parkinsonism. Inclusion of SWEDD participants in PD biomarker studies or therapeutic trials may therefore cause them to fail. DaTScan can identify SWEDD individuals, but it is expensive and not widely available; an alternative imaging approach is needed. Here, we evaluate the use of neuromelanin-sensitive, iron-sensitive, and diffusion contrasts in substantia nigra pars compacta (SNpc) to differentiate SWEDD from PD individuals. Neuromelanin-sensitive, iron-sensitive, and diffusion imaging data for SWEDD, PD, and control subjects were downloaded from the Parkinson’s progression markers initiative (PPMI) database. SNpc volume, SNpc iron (R2), and SNpc free water (FW) were measured for each participant. Significantly smaller SNpc volume was seen in PD as compared to SWEDD (P < 10–3) and control (P < 10–3) subjects. SNpc FW was elevated in the PD group relative to controls (P = 0.017). No group difference was observed in SNpc R2. In conclusion, nigral volume and FW in the SWEDD group were similar to that of controls, while a reduction in nigral volume and increased FW were observed in the PD group relative to SWEDD and control participants. These results suggest that these MRI measures should be explored as a cost-effective alternative to DaTScan for evaluation of the nigrostriatal system.
登录
查看更多内容
DOI:
10.1093/brain/awab191
发表时间:
2021-11-29
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Biondetti E;Santin MD;Valabrègue R;Mangone G;Gaurav R;Pyatigorskaya N;Hutchison M;Yahia-Cherif L;Villain N;Habert MO;Arnulf I;Leu-Semenescu S;Dodet P;Vila M;Corvol JC;Vidailhet M;Lehéricy S
通讯作者:
Lehéricy S
影响因子:
3.5
作者:
Garyfallidis E;Brett M;Amirbekian B;Rokem A;van der Walt S;Descoteaux M;Nimmo-Smith I;Dipy Contributors
通讯作者:
Dipy Contributors
影响因子:
4.8
作者:
Jin Z;Wang Y;Jokar M;Li Y;Cheng Z;Liu Y;Tang R;Shi X;Zhang Y;Min J;Liu F;He N;Yan F;Haacke EM
通讯作者:
Haacke EM
DOI:
10.1093/brain/awx146
发表时间:
2017-08-01
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Burciu RG;Ofori E;Archer DB;Wu SS;Pasternak O;McFarland NR;Okun MS;Vaillancourt DE
通讯作者:
Vaillancourt DE
影响因子:
2.8
作者:
Kitao, Shinichiro;Matsusue, Eiji;Ogawa, Toshihide
通讯作者:
Ogawa, Toshihide